IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections

Pseudomonas aeruginosa (P.a) infections are a major public health issue in ventilator-associated pneumoniae, cystic fibrosis, and chronic obstructive pulmonary disease exacerbations. P.a is multidrug resistant, and there is an urgent need to develop new therapeutic approaches. Here, we evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kheir, Saadé, Villeret, Bérengère, Garcia-Verdugo, Ignacio, Sallenave, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753374/
https://www.ncbi.nlm.nih.gov/pubmed/34371178
http://dx.doi.org/10.1016/j.ymthe.2021.08.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753374/
https://www.ncbi.nlm.nih.gov/pubmed/34371178
http://dx.doi.org/10.1016/j.ymthe.2021.08.007

Ejemplares similares